313 related articles for article (PubMed ID: 22341944)
1. Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Tang H; Zhao HT; Zhong SM; Wang ZY; Chen ZF; Liang H
Bioorg Med Chem Lett; 2012 Mar; 22(6):2257-61. PubMed ID: 22341944
[TBL] [Abstract][Full Text] [Related]
2. Hybrids of oxoisoaporphine-tacrine congeners: novel acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation inhibitors.
Tang H; Zhao LZ; Zhao HT; Huang SL; Zhong SM; Qin JK; Chen ZF; Huang ZS; Liang H
Eur J Med Chem; 2011 Oct; 46(10):4970-9. PubMed ID: 21871694
[TBL] [Abstract][Full Text] [Related]
3. Multitarget-directed oxoisoaporphine derivatives: Anti-acetylcholinesterase, anti-β-amyloid aggregation and enhanced autophagy activity against Alzheimer's disease.
Wei S; Chen W; Qin J; Huangli Y; Wang L; Shen Y; Tang H
Bioorg Med Chem; 2016 Nov; 24(22):6031-6039. PubMed ID: 27720328
[TBL] [Abstract][Full Text] [Related]
4. Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
Camps P; Formosa X; Galdeano C; Muñoz-Torrero D; Ramírez L; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Huertas O; Dafni T; Luque FJ
J Med Chem; 2009 Sep; 52(17):5365-79. PubMed ID: 19663388
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
6. 4- Substituted sampangine derivatives: Novel acetylcholinesterase and β-myloid aggregation inhibitors.
Chen KL; Gan L; Wu ZH; Qin JF; Liao WX; Tang H
Int J Biol Macromol; 2018 Feb; 107(Pt B):2725-2729. PubMed ID: 29111270
[TBL] [Abstract][Full Text] [Related]
7. New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.
Rouleau J; Iorga BI; Guillou C
Eur J Med Chem; 2011 Jun; 46(6):2193-205. PubMed ID: 21435752
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase.
Tang H; Wei YB; Zhang C; Ning FX; Qiao W; Huang SL; Ma L; Huang ZS; Gu LQ
Eur J Med Chem; 2009 Jun; 44(6):2523-32. PubMed ID: 19243862
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
Shan WJ; Huang L; Zhou Q; Meng FC; Li XS
Eur J Med Chem; 2011 Dec; 46(12):5885-93. PubMed ID: 22019228
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents.
Luo W; Li YP; He Y; Huang SL; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2011 Jun; 46(6):2609-16. PubMed ID: 21497959
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of derivatives of cleistopholine and their anti-acetylcholinesterase and anti-β-amyloid aggregation activity.
Wu Z; Liao W; Chen K; Qin J; Tang H
Bioorg Chem; 2018 Feb; 76():228-236. PubMed ID: 29195093
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A
Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363
[TBL] [Abstract][Full Text] [Related]
14. Syntheses and characterization of novel oxoisoaporphine derivatives as dual inhibitors for cholinesterases and amyloid beta aggregation.
Li YP; Ning FX; Yang MB; Li YC; Nie MH; Ou TM; Tan JH; Huang SL; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2011 May; 46(5):1572-81. PubMed ID: 21367493
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of isaindigotone derivatives as dual inhibitors for acetylcholinesterase and amyloid beta aggregation.
Yan JW; Li YP; Ye WJ; Chen SB; Hou JQ; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
Bioorg Med Chem; 2012 Apr; 20(8):2527-34. PubMed ID: 22444876
[TBL] [Abstract][Full Text] [Related]
16. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Camps P; Formosa X; Galdeano C; Gómez T; Muñoz-Torrero D; Scarpellini M; Viayna E; Badia A; Clos MV; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Estelrich J; Lizondo M; Bidon-Chanal A; Luque FJ
J Med Chem; 2008 Jun; 51(12):3588-98. PubMed ID: 18517184
[TBL] [Abstract][Full Text] [Related]
17. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
[TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR studies of azaoxoisoaporphine, oxoaporphine, and oxoisoaporphine derivatives as anti-AChE and anti-AD agents by the CoMFA method.
Li YP; Weng X; Ning FX; Ou JB; Hou JQ; Luo HB; Li D; Huang ZS; Huang SL; Gu LQ
J Mol Graph Model; 2013 Apr; 41():61-7. PubMed ID: 23500628
[TBL] [Abstract][Full Text] [Related]
19. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
[TBL] [Abstract][Full Text] [Related]
20. Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Bartolini M; Bottegoni G; Bisi A; Cavalli A; Andrisano V; Rampa A
Eur J Med Chem; 2011 May; 46(5):1682-93. PubMed ID: 21397996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]